Table 2 Reason for changing or remaining on therapy (safety set)
LABA/LAMA FDC (N = 340) | Triple therapy (N = 784) | ||
|---|---|---|---|
Reason to change therapy*, n (%) | Reason to remain on therapy†, n (%) | ||
Physician prefers other inhaler | 14 (4.1) | Physician prefers current inhaler(s) | 61 (7.8) |
Physician prefers FDC | 56 (16.5) | Established control of COPD symptoms | 275 (35.1) |
Exacerbation(s) with current COPD medication | 1 (0.3) | Good tolerability | 101 (12.9) |
Side effect(s) with current COPD medication | 5 (1.5) | Patient prefers current inhaler(s) | 34 (4.3) |
Patient still symptomatic with current COPD medication | 25 (7.4) | Patient's wish | 37 (4.7) |
Patient prefers FDC | 31 (9.1) | Considered necessary for exacerbation prevention | 255 (32.5) |
Patient prefers other inhaler | 10 (2.9) | Other main reason | 12 (1.5) |
Patient's wish | 87 (25.6) | Missing values | 9 (1.1) |
Other main reason | 96 (28.2) | ||
Missing values | 15 (4.4) | ||